SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

The Power Over Prostate and Testicular Cancer Gathering was again held on Nov. 8 at Springhill Missionary Baptist Church in southeast Gainesville.

Metformin does not delay disease progression in men with low risk prostate cancer on active surveillance and is associated ...

His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...